MedPath

Effective dose of remifentanil for control of hemodynamic response to insertion of the Streamlined Liner of the Pharyngeal Airway(SLIPA)

Phase 4
Completed
Conditions
Hemodynamic response to insertion of the Streamlined Liner of the Pharyngeal Airway(SLIPA)
Anaesthesiology - Other anaesthesiology
Registration Number
ACTRN12613000086763
Lead Sponsor
Chung-Ang University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria

Patients with healthy and aged 20-65 years old, who were planned general anesthesia.

Exclusion Criteria

cardiovascular or pulmonary disease, reflux esophagitis, obesity (BMI > 30 kg/m²), or were pregnant, or were addicted to opioids, sedatives, or other medications

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Systolic Blood Pressure by noninvasive blood pressure cuff[postinsertion 1, 2, 3 min ];Mean Arterial Pressure by noninvasive blood pressure cuff[post insertion 1,2,3 min]; Diastolic Blood Pressure by noninvasive blood pressure cuff[Post intubation 1,2,3 min]
Secondary Outcome Measures
NameTimeMethod
Heart Rate by electrocardiogram[1, 2, 3 min postinsertion]
© Copyright 2025. All Rights Reserved by MedPath